FR2814367B1 - NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA - Google Patents

NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA

Info

Publication number
FR2814367B1
FR2814367B1 FR0012164A FR0012164A FR2814367B1 FR 2814367 B1 FR2814367 B1 FR 2814367B1 FR 0012164 A FR0012164 A FR 0012164A FR 0012164 A FR0012164 A FR 0012164A FR 2814367 B1 FR2814367 B1 FR 2814367B1
Authority
FR
France
Prior art keywords
hyperalgia
pain
treatment
receptor ligands
npff receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0012164A
Other languages
French (fr)
Other versions
FR2814367A1 (en
Inventor
Jean Jacques Bourguignon
Jean Paul Macher
Martine Schmitt
Guy Simonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR0012164A priority Critical patent/FR2814367B1/en
Priority to PCT/FR2001/002973 priority patent/WO2002024192A1/en
Priority to AU2001291994A priority patent/AU2001291994A1/en
Publication of FR2814367A1 publication Critical patent/FR2814367A1/en
Application granted granted Critical
Publication of FR2814367B1 publication Critical patent/FR2814367B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
FR0012164A 2000-09-25 2000-09-25 NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA Expired - Fee Related FR2814367B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0012164A FR2814367B1 (en) 2000-09-25 2000-09-25 NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA
PCT/FR2001/002973 WO2002024192A1 (en) 2000-09-25 2001-09-25 Dipeptide ligands of the npff receptor for treating pain and hyperalgesia
AU2001291994A AU2001291994A1 (en) 2000-09-25 2001-09-25 Dipeptide ligands of the npff receptor for treating pain and hyperalgesia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0012164A FR2814367B1 (en) 2000-09-25 2000-09-25 NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA

Publications (2)

Publication Number Publication Date
FR2814367A1 FR2814367A1 (en) 2002-03-29
FR2814367B1 true FR2814367B1 (en) 2008-12-26

Family

ID=8854636

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0012164A Expired - Fee Related FR2814367B1 (en) 2000-09-25 2000-09-25 NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA

Country Status (3)

Country Link
AU (1) AU2001291994A1 (en)
FR (1) FR2814367B1 (en)
WO (1) WO2002024192A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276249B2 (en) 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
JPWO2004080965A1 (en) * 2003-03-14 2006-06-08 協和醗酵工業株式会社 Neuropeptide FF receptor antagonist
CL2004000553A1 (en) 2003-03-20 2005-02-04 Actelion Pharmaceuticals Ltd USE OF GUANIDINE DERIVATIVE COMPOUNDS AS ANTAGONISTS OF THE FF NEUROPEPTIDE RECEIVER; COMPOUNDS DERIVED FROM GUANIDINA; PREPARATION PROCEDURES; AND PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM.
FI20031454A0 (en) 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selective somatostatin receptor 1 and / or 4 agonists and antagonists
EP2669276A1 (en) 2012-05-31 2013-12-04 Université de Strasbourg Ornithine- and lysine-derivatives for the treatment of pain
KR102375543B1 (en) * 2017-07-21 2022-03-16 스촨 하이스코 파마수티컬 씨오., 엘티디 Peptide amide compounds and methods for their preparation and use in medicine
AU2019213484A1 (en) 2018-02-05 2020-07-02 Centre National De La Recherche Scientifique Compounds and compositions for the treatment of pain
CA3144527A1 (en) 2019-08-06 2021-02-11 Domain Therapeutics 5-heteroaryl-pyridin-2-amine confounds as neuropeptide ff receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4326465A1 (en) * 1993-01-20 1995-02-09 Thomae Gmbh Dr K Amino acid derivatives, pharmaceutical compositions containing these compounds and process for their preparation
GB9500601D0 (en) * 1995-01-12 1995-03-01 Wellcome Found Modified peptides
DE19544686A1 (en) * 1995-11-30 1997-06-05 Thomae Gmbh Dr K Amino acid derivatives, medicaments containing these compounds and processes for their preparation
US6262246B1 (en) * 1998-09-25 2001-07-17 Synaptic Pharmaceutical Corporation DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof

Also Published As

Publication number Publication date
AU2001291994A1 (en) 2002-04-02
WO2002024192A1 (en) 2002-03-28
FR2814367A1 (en) 2002-03-29

Similar Documents

Publication Publication Date Title
MA26852A1 (en) SELECTIVE AGONISTS OF THE EP4 RECEPTOR FOR THE TREATMENT OF OSTEOPOROSIS
FR13C0060I2 (en) FLUORO-SUBSTITUTED OMEGA-CARBOXYARYLDIPHENYLUREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS
DE60112340D1 (en) Absorbent mat for the treatment of excreta
DE60114808D1 (en) SURFACE TREATMENT OF MEDICAL DEVICE
FR05C0033I2 (en) R-ENANTIOMER OF N-PROPARGYL-1-AMINO-INDANE FOR THE TREATMENT OF VARIOUS DISEASES AND ITS MESYLATE, ESYLATE AND SULFATE
DE69825447D1 (en) DERMATOLOGICAL TREATMENT DEVICE
DZ3442A1 (en) COMBINATION OF FENOFIBRATE AND COENZYME Q10 FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION
NO20042208L (en) Vaginally administered anti-dysrhythmic agents for the treatment of pelvic pain
FR2816513B1 (en) SUBCUTANEOUS VALVE FOR THE TREATMENT OF HYDROCEPHALIA AND ITS ADJUSTMENT DEVICES
FR2775078B1 (en) METHOD AND DEVICE FOR THE TREATMENT OF DISHWASHER IN DISHWASHER
DZ3209A1 (en) Selective iGLuR5 receptor antagonists used in the treatment of migraine.
DE60136477D1 (en) RETINOIDES FOR THE TREATMENT OF EMPHYSEM
FR2815541B1 (en) USE OF PERICYTE APOPTOSIS INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF DIABETIC RETINOPATHY
DE60037240D1 (en) VIBRATION MASSAGE DEVICE FOR PAIN TREATMENT
FR2778330B1 (en) APPARATUS FOR ORTHODONTIC TREATMENT
FR2818917B1 (en) FILTER FOR THE PARTICULATE DEPOLLUTION OF FLUIDS
FR2814367B1 (en) NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA
DE69620691D1 (en) Therapeutic agent for the treatment of hypercholesterolemia
DE60016047D1 (en) DIHYDROBENZOPYRANE, DIHYDROBENZOTHIOPYRANE AND TETRAHYDROCHINOLINE FOR THE TREATMENT OF COX-2-DEPENDENT DISEASES
ATE358483T1 (en) SELECTIVE DOPAMINE D4 RECEPTOR AGONISTS FOR THE TREATMENT OF SEXUAL DYSFUNCTIONS
MA25852A1 (en) METHOD FOR THE TREATMENT OF INFLAMMATION.
DZ3320A1 (en) Complex comprising eletriptane and sulphobutylether-cyclodextrin for the treatment of migraine
DE60025215D1 (en) L-ACETYLCARNITINE AND L-PROPIONYLCARNITINE COMPOSITION FOR THE PREVENTION AND TREATMENT OF KIDNEY DISORDERS AND RENAL DISEASE
FR2800614B1 (en) COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS
FR2786096B1 (en) COMPOSITION FOR THE PREVENTION AND TOPICAL TREATMENT OF CELLULITE

Legal Events

Date Code Title Description
TQ Partial transmission of property
TQ Partial transmission of property
ST Notification of lapse

Effective date: 20120531